Skip to content

Prevalenza Della Insulino Resistenza e Correlate Malattie Cardiovascolari Nella città di Napoli

Studio Epidemilogico Per Valutare la Prevalenza Della Insulino Resistenza Nell'Area Metropolitana di Napoli e Della Sua Relazione Con Malattie Cardiovascolari

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07785518
Enrollment
123752
Registered
2026-08-25
Start date
2026-01-25
Completion date
2026-06-30
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardio Vascular Disease, Insulin Resistance Syndrome, Prevalence

Keywords

Insulin Resistance, Cardiovascular disease, Hyperinsulinemia, Prevalence

Brief summary

This is an observational retrospective study to verify the prevalence of insulin resistance (IR) in the municipality of Naples and ita association with cardiovascular diseases. Primary outcome measure 1: The prevalence of IR. Primary outcome measure 2: The prevalence of cardiovascular diseases in subjects with IRnand in subjects without IR. The data for analysis will be derived from the database of COMEGEN, a cooperative of general practitioners (ASL Napoli 1 Centro)who follow about 200,000 individuals of the ten districts of the municipality of Naples. As surrogate index of IR will be used the TyG with the cutoff ≥8.5. Aldo the prevalence of cardiovascular diseases in the two groups will be derivedby the registered cardiovascular diseases in the database.

Interventions

OTHERNo Intervention: Observational Cohort

There is no intervention

Sponsors

Comune di Napoli
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* all the subjects who have a registered value of glucose and triglycerides in the same day within the last 6 months

Exclusion criteria

* diagnosis of overt diabetes

Design outcomes

Primary

MeasureTime frame
Prevalence of insulin resistance30 days

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026